Company Number: 13889815

Analysis Date: 2025-07-20 18:54 UTC

1. Strategic Assets: Blueberry Scientific Limited is a recently incorporated private limited company operating within the venture and development capital sector (SIC Code 64303). It is currently dormant, with minimal financial activity and assets limited to £100 in cash and share capital. The company benefits from a streamlined ownership and governance structure, with a single principal owner and director holding full control over shares and voting rights. This concentrated control may enable rapid decision-making and strategic pivots once operational.

2. Growth Opportunities: Given its current dormant status and capital base, Blueberry Scientific Limited stands at an early developmental stage with substantial runway for growth. The company could capitalize on emerging investment opportunities in scientific and technological ventures, leveraging its venture capital designation. Strategic growth could be achieved by raising additional capital, building a diversified investment portfolio, and forming partnerships with innovative startups. Additionally, the company should consider scaling operational capabilities to transition from dormancy to active investment and management.

3. Strategic Risks: The primary risk lies in the company's nascent stage and limited financial resources, which constrain its ability to influence or participate significantly in the venture capital market immediately. Dependence on a sole director/investor concentrates operational and strategic risk, including succession and decision-making bottlenecks. The dormant status also implies a lack of operational history, which may challenge credibility and fundraising efforts. Furthermore, the competitive nature of venture capital demands robust deal sourcing and due diligence capabilities, which are currently undeveloped.

4. Market Position: Blueberry Scientific Limited currently occupies a foundational position within the venture capital industry, with no active market presence or portfolio. Its small scale and dormant filing status mean it functions more as a holding or shell entity at this stage. To establish a competitive market position, the company must activate its operational strategy, secure funding, and differentiate through targeted investments in high-growth scientific ventures. Its London location places it in a strategic geographic hub for access to innovation ecosystems.